NEW YORK (GenomeWeb News) – Israeli seed and breeding technology firm Kaiima Bio Agri-Tech today announced it closed on a financing round that raised US$65 million.

Three new investors participated in the round — Horizons Ventures; the International Financial Corporation, a member of the World Bank Group; and the Infinity Group. Participating existing investors included Draper Fisher Jurvetson; DFJ-Tamir Fishman Ventures; Mitsui Global Investment; Kleiner Perkins Caufield & Byers; Oberlee; and Musea Ventures.

Kaiima did not specify how the financing will be used.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: the Human Silencing Hub protein complex, and more.

Heads of various research funding agencies discuss how to encourage scientific breakthroughs, ScienceInsider reports.

The Kansas City Star examines issues surrounding newborn genome sequencing.

Researchers say their Research Resource Identifier citation format is catching on, Nature News reports.